| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.89e-05 | 25 | 48 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 3.38e-05 | 4 | 48 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.35e-04 | 891 | 48 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | RYBP NRG1 UBQLN2 TCERG1 SNAP91 HIPK1 ZMYND8 KDM3B NUP62 PIAS2 | 3.64e-04 | 1160 | 48 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.65e-04 | 562 | 48 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.07e-03 | 188 | 48 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | RYBP NRG1 UBQLN2 TCERG1 SNAP91 HIPK1 ZMYND8 KDM3B NUP62 PIAS2 | 1.23e-03 | 1356 | 48 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.27e-03 | 22 | 48 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.91e-03 | 27 | 48 | 2 | GO:0008139 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.21e-03 | 229 | 48 | 4 | GO:0003714 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.12e-10 | 109 | 47 | 8 | GO:0005796 | |
| Domain | SEA | 3.28e-07 | 23 | 48 | 4 | PS50024 | |
| Domain | SEA_dom | 3.28e-07 | 23 | 48 | 4 | IPR000082 | |
| Domain | TIL | 3.45e-06 | 12 | 48 | 3 | PF01826 | |
| Domain | C8 | 3.45e-06 | 12 | 48 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.47e-06 | 13 | 48 | 3 | IPR014853 | |
| Domain | C8 | 4.47e-06 | 13 | 48 | 3 | SM00832 | |
| Domain | SEA | 5.68e-06 | 14 | 48 | 3 | SM00200 | |
| Domain | TIL_dom | 5.68e-06 | 14 | 48 | 3 | IPR002919 | |
| Domain | Mucin_dom | 6.47e-06 | 2 | 48 | 2 | IPR028199 | |
| Domain | Epiglycanin_C | 6.47e-06 | 2 | 48 | 2 | PF14654 | |
| Domain | VWD | 8.71e-06 | 16 | 48 | 3 | SM00216 | |
| Domain | VWF_type-D | 8.71e-06 | 16 | 48 | 3 | IPR001846 | |
| Domain | VWFD | 8.71e-06 | 16 | 48 | 3 | PS51233 | |
| Domain | VWD | 8.71e-06 | 16 | 48 | 3 | PF00094 | |
| Domain | VWC_out | 1.50e-05 | 19 | 48 | 3 | SM00215 | |
| Domain | SEA | 2.37e-05 | 22 | 48 | 3 | PF01390 | |
| Domain | CT | 2.37e-05 | 22 | 48 | 3 | SM00041 | |
| Domain | Cys_knot_C | 3.52e-05 | 25 | 48 | 3 | IPR006207 | |
| Domain | CTCK_2 | 3.52e-05 | 25 | 48 | 3 | PS01225 | |
| Domain | HECT | 4.46e-05 | 27 | 48 | 3 | PF00632 | |
| Domain | HECTc | 4.46e-05 | 27 | 48 | 3 | SM00119 | |
| Domain | HECT_dom | 4.46e-05 | 27 | 48 | 3 | IPR000569 | |
| Domain | HECT | 4.46e-05 | 27 | 48 | 3 | PS50237 | |
| Domain | WxxW_domain | 9.64e-05 | 6 | 48 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.64e-05 | 6 | 48 | 2 | PF13330 | |
| Domain | VWF_dom | 1.70e-04 | 42 | 48 | 3 | IPR001007 | |
| Domain | WWE | 4.20e-04 | 12 | 48 | 2 | PS50918 | |
| Domain | WWE | 4.20e-04 | 12 | 48 | 2 | PF02825 | |
| Domain | WWE-dom | 4.20e-04 | 12 | 48 | 2 | IPR004170 | |
| Domain | Glyco_hormone_CN | 6.65e-04 | 15 | 48 | 2 | IPR006208 | |
| Domain | Cys_knot | 6.65e-04 | 15 | 48 | 2 | PF00007 | |
| Domain | - | 6.65e-04 | 15 | 48 | 2 | 3.30.70.960 | |
| Domain | CTCK_1 | 9.64e-04 | 18 | 48 | 2 | PS01185 | |
| Domain | zf-RanBP | 1.45e-03 | 22 | 48 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 1.58e-03 | 23 | 48 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 1.58e-03 | 23 | 48 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 1.72e-03 | 24 | 48 | 2 | PS01358 | |
| Domain | ARM-type_fold | 1.73e-03 | 339 | 48 | 5 | IPR016024 | |
| Domain | Znf_RanBP2 | 1.87e-03 | 25 | 48 | 2 | IPR001876 | |
| Domain | VWC | 2.34e-03 | 28 | 48 | 2 | PF00093 | |
| Domain | UBA | 2.69e-03 | 30 | 48 | 2 | SM00165 | |
| Domain | UBA | 3.85e-03 | 36 | 48 | 2 | PF00627 | |
| Domain | VWFC_1 | 3.85e-03 | 36 | 48 | 2 | PS01208 | |
| Domain | EGF_1 | 4.12e-03 | 255 | 48 | 4 | PS00022 | |
| Domain | VWC | 4.29e-03 | 38 | 48 | 2 | SM00214 | |
| Domain | Bromodomain | 4.29e-03 | 38 | 48 | 2 | PF00439 | |
| Domain | VWFC_2 | 4.29e-03 | 38 | 48 | 2 | PS50184 | |
| Domain | EGF-like_CS | 4.48e-03 | 261 | 48 | 4 | IPR013032 | |
| Domain | EGF_2 | 4.72e-03 | 265 | 48 | 4 | PS01186 | |
| Domain | BROMODOMAIN_2 | 4.98e-03 | 41 | 48 | 2 | PS50014 | |
| Domain | ARM-like | 5.05e-03 | 270 | 48 | 4 | IPR011989 | |
| Domain | BROMO | 5.22e-03 | 42 | 48 | 2 | SM00297 | |
| Domain | Bromodomain | 5.22e-03 | 42 | 48 | 2 | IPR001487 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.52e-17 | 16 | 40 | 8 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.76e-17 | 17 | 40 | 8 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.48e-16 | 23 | 40 | 8 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.00e-15 | 26 | 40 | 8 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.04e-12 | 62 | 40 | 8 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.30e-11 | 68 | 40 | 8 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.85e-11 | 21 | 40 | 6 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.14e-10 | 111 | 40 | 8 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.55e-09 | 140 | 40 | 8 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.38e-09 | 143 | 40 | 8 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.58e-08 | 60 | 40 | 6 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.12e-07 | 250 | 40 | 8 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.77e-07 | 109 | 40 | 6 | MM15164 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.25e-06 | 39 | 40 | 4 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.08e-06 | 47 | 40 | 4 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.32e-05 | 65 | 40 | 4 | MM15147 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.71e-05 | 71 | 40 | 4 | M27394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.48e-05 | 77 | 40 | 4 | M27226 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 9.10e-05 | 84 | 40 | 4 | MM14929 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 9.92e-05 | 32 | 40 | 3 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 1.09e-04 | 33 | 40 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.19e-04 | 34 | 40 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.30e-04 | 35 | 40 | 3 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.42e-04 | 36 | 40 | 3 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.42e-04 | 36 | 40 | 3 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.54e-04 | 37 | 40 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.54e-04 | 37 | 40 | 3 | M27038 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.94e-04 | 40 | 40 | 3 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.09e-04 | 41 | 40 | 3 | MM15200 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 2.09e-04 | 41 | 40 | 3 | M29574 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | MUC21 MUC17 NCKIPSD MUC16 NFASC MUC5B MUC12 HUWE1 MUC3A MUC5AC MUC6 | 2.17e-04 | 1128 | 40 | 11 | M1036 |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.25e-04 | 42 | 40 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.41e-04 | 43 | 40 | 3 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.41e-04 | 43 | 40 | 3 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.59e-04 | 44 | 40 | 3 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.95e-04 | 46 | 40 | 3 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.15e-04 | 47 | 40 | 3 | M27395 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.56e-04 | 49 | 40 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.78e-04 | 50 | 40 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.01e-04 | 51 | 40 | 3 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.49e-04 | 53 | 40 | 3 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.75e-04 | 54 | 40 | 3 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 5.01e-04 | 55 | 40 | 3 | MM14917 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | MUC21 POM121 MUC17 MUC16 MUC5B NUP62 MUC12 POM121C PIAS2 MUC3A MUC5AC MUC6 | 5.64e-04 | 1475 | 40 | 12 | M19806 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.86e-04 | 58 | 40 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.86e-04 | 58 | 40 | 3 | MM14736 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 6.16e-04 | 59 | 40 | 3 | M27606 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.06e-03 | 277 | 40 | 5 | MM15414 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.15e-03 | 73 | 40 | 3 | MM14948 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.17e-03 | 283 | 40 | 5 | M13087 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.19e-03 | 74 | 40 | 3 | M48006 | |
| Pathway | REACTOME_SUMOYLATION | 1.30e-03 | 169 | 40 | 4 | MM14919 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.60e-03 | 82 | 40 | 3 | MM15394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.60e-03 | 82 | 40 | 3 | M27250 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.72e-03 | 84 | 40 | 3 | M725 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.78e-03 | 85 | 40 | 3 | MM14906 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.78e-03 | 85 | 40 | 3 | M1870 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.84e-03 | 86 | 40 | 3 | MM15413 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.90e-03 | 87 | 40 | 3 | M27194 | |
| Pathway | REACTOME_SUMOYLATION | 1.96e-03 | 189 | 40 | 4 | M27214 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 2.08e-03 | 24 | 40 | 2 | MM15658 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.23e-03 | 92 | 40 | 3 | MM14951 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 2.26e-03 | 25 | 40 | 2 | MM15546 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 2.63e-03 | 27 | 40 | 2 | M29807 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES | 2.63e-03 | 27 | 40 | 2 | M47941 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.75e-03 | 99 | 40 | 3 | M27474 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.91e-03 | 101 | 40 | 3 | M27253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 3.25e-03 | 30 | 40 | 2 | M47752 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.34e-03 | 106 | 40 | 3 | M27458 | |
| Pathway | WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME | 3.34e-03 | 106 | 40 | 3 | M40052 | |
| Pathway | REACTOME_TRNA_PROCESSING | 3.80e-03 | 111 | 40 | 3 | M27684 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.09e-03 | 114 | 40 | 3 | MM15361 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 4.16e-03 | 34 | 40 | 2 | M27826 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 4.30e-03 | 116 | 40 | 3 | M29806 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | MUC21 POM121 MUC17 MUC16 MUC5B NUP62 POM121C PIAS2 MUC5AC MUC6 | 4.50e-03 | 1389 | 40 | 10 | MM15307 |
| Pathway | REACTOME_M_PHASE | 4.54e-03 | 387 | 40 | 5 | MM15364 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 4.69e-03 | 561 | 40 | 6 | M5336 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 5.41e-03 | 126 | 40 | 3 | M45009 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 6.03e-03 | 131 | 40 | 3 | M5283 | |
| Pathway | REACTOME_M_PHASE | 6.20e-03 | 417 | 40 | 5 | M27662 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 6.55e-03 | 135 | 40 | 3 | M15247 | |
| Pathway | REACTOME_CELL_CYCLE | 6.64e-03 | 603 | 40 | 6 | MM14635 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 6.96e-03 | 138 | 40 | 3 | M29805 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.10e-03 | 139 | 40 | 3 | M715 | |
| Pathway | PID_ILK_PATHWAY | 7.20e-03 | 45 | 40 | 2 | M71 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 7.53e-03 | 142 | 40 | 3 | M27660 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 8.59e-03 | 149 | 40 | 3 | M4076 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.91e-03 | 151 | 40 | 3 | M550 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 9.90e-03 | 157 | 40 | 3 | M4669 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.08e-02 | 162 | 40 | 3 | M29804 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.21e-16 | 18 | 49 | 7 | 18834073 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 19110483 | ||
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 2.63e-09 | 3 | 49 | 3 | 19556605 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 23807779 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 17471237 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 14984930 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.05e-08 | 4 | 49 | 3 | 29869461 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NHSL1 TCERG1 PPP1R12A KIF1B NCKIPSD CKAP5 KDM3B NUP62 HECTD1 TRIP12 PLK4 | 2.48e-08 | 861 | 49 | 11 | 36931259 |
| Pubmed | 3.75e-07 | 486 | 49 | 8 | 20936779 | ||
| Pubmed | 1.13e-06 | 130 | 49 | 5 | 12421765 | ||
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 14697343 | ||
| Pubmed | 1.22e-06 | 777 | 49 | 9 | 35844135 | ||
| Pubmed | UBQLN2 TCERG1 CLIP2 HIPK1 KIF1B ZMYND8 CKAP5 HUWE1 PIAS2 HECTD1 TRIP12 | 1.34e-06 | 1285 | 49 | 11 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RYBP BPTF SFSWAP TCERG1 ZMYND8 CKAP5 RBM5 NUP62 POM121C MGA TRIP12 | 1.44e-06 | 1294 | 49 | 11 | 30804502 |
| Pubmed | 1.62e-06 | 591 | 49 | 8 | 15231748 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 7513696 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.94e-06 | 2 | 49 | 2 | 23272068 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.94e-06 | 2 | 49 | 2 | 27729120 | |
| Pubmed | Mucins: a biologically relevant glycan barrier in mucosal protection. | 1.94e-06 | 2 | 49 | 2 | 24821013 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 34058148 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.94e-06 | 2 | 49 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.94e-06 | 2 | 49 | 2 | 14988081 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16540890 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15563276 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 36111525 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18782111 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17621824 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22220206 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.94e-06 | 2 | 49 | 2 | 27845589 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22391959 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.94e-06 | 2 | 49 | 2 | 35776514 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27435107 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24327612 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26871672 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.94e-06 | 2 | 49 | 2 | 21653907 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28321513 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 9422745 | ||
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.94e-06 | 2 | 49 | 2 | 36427316 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11988092 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.94e-06 | 2 | 49 | 2 | 32348677 | |
| Pubmed | Membrane-bound mucin modular domains: from structure to function. | 1.94e-06 | 2 | 49 | 2 | 23178705 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.94e-06 | 2 | 49 | 2 | 11587997 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.94e-06 | 2 | 49 | 2 | 28607090 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12360467 | ||
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 1.94e-06 | 2 | 49 | 2 | 24722639 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.94e-06 | 2 | 49 | 2 | 24332705 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.94e-06 | 2 | 49 | 2 | 34656442 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.73e-06 | 857 | 49 | 9 | 25609649 | |
| Pubmed | 2.77e-06 | 156 | 49 | 5 | 37108203 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.87e-06 | 283 | 49 | 6 | 30585729 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33232357 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27776277 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18300795 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 5.83e-06 | 3 | 49 | 2 | 34158522 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19924550 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 5.83e-06 | 3 | 49 | 2 | 30802453 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 5.83e-06 | 3 | 49 | 2 | 29604272 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 29286856 | ||
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 5.83e-06 | 3 | 49 | 2 | 19596978 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27230679 | ||
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 5.83e-06 | 3 | 49 | 2 | 17227128 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 36675209 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 5.83e-06 | 3 | 49 | 2 | 18163520 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 35507432 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23828549 | ||
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 5.83e-06 | 3 | 49 | 2 | 21455588 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 29802623 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 5.83e-06 | 3 | 49 | 2 | 20422702 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20981447 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26770020 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18825309 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19718741 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 10512748 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.50e-06 | 954 | 49 | 9 | 36373674 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.16e-06 | 332 | 49 | 6 | 32786267 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.01e-05 | 95 | 49 | 4 | 29643511 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 21596555 | ||
| Pubmed | HUWE1 and TRIP12 collaborate in degradation of ubiquitin-fusion proteins and misframed ubiquitin. | 1.16e-05 | 4 | 49 | 2 | 23209776 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 33154304 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 1.16e-05 | 4 | 49 | 2 | 31582416 | |
| Pubmed | Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. | 1.16e-05 | 4 | 49 | 2 | 24603585 | |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 1.16e-05 | 4 | 49 | 2 | 24901817 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 1.16e-05 | 4 | 49 | 2 | 27298226 | |
| Pubmed | Identification of FHOD1-binding proteins and mechanisms of FHOD1-regulated actin dynamics. | 1.16e-05 | 4 | 49 | 2 | 15095401 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 25638393 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 36367122 | ||
| Pubmed | E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation. | 1.16e-05 | 4 | 49 | 2 | 20624960 | |
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 1.16e-05 | 4 | 49 | 2 | 21097527 | |
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.16e-05 | 4 | 49 | 2 | 22269464 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 23249391 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 1.16e-05 | 4 | 49 | 2 | 17401217 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.16e-05 | 4 | 49 | 2 | 17900573 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 1.16e-05 | 4 | 49 | 2 | 18258655 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 1.16e-05 | 4 | 49 | 2 | 20929551 | |
| Interaction | YWHAH interactions | NHSL1 SFSWAP TCERG1 PPP1R12A KIF1B NCKIPSD CKAP5 KDM3B NUP62 HUWE1 PIAS2 HECTD1 TRIP12 PLK4 | 1.23e-07 | 1102 | 47 | 14 | int:YWHAH |
| Interaction | TERF2IP interactions | 4.38e-06 | 552 | 47 | 9 | int:TERF2IP | |
| Interaction | NUP43 interactions | BPTF POM121 CDKN2AIP PPP1R12A ZMYND8 NUP62 POM121C MGA TRIP12 | 1.19e-05 | 625 | 47 | 9 | int:NUP43 |
| Interaction | YWHAG interactions | NHSL1 TCERG1 PPP1R12A KIF1B NCKIPSD CKAP5 KDM3B NUP62 HUWE1 HECTD1 TRIP12 PLK4 | 2.08e-05 | 1248 | 47 | 12 | int:YWHAG |
| Interaction | YWHAZ interactions | NHSL1 NRG1 CLIP2 PPP1R12A KIF1B NCKIPSD CKAP5 HUWE1 HECTD1 TRIP12 PLK4 ITPKA | 3.60e-05 | 1319 | 47 | 12 | int:YWHAZ |
| Interaction | XRCC6 interactions | BPTF UBQLN2 TCERG1 CDKN2AIP ZMYND8 HUWE1 MGA PIAS2 HECTD1 TRIP12 | 4.47e-05 | 928 | 47 | 10 | int:XRCC6 |
| Interaction | ABI2 interactions | 5.11e-05 | 286 | 47 | 6 | int:ABI2 | |
| Interaction | SMC5 interactions | BPTF SFSWAP TCERG1 SNAP91 CDKN2AIP ZMYND8 NUP62 MGA HECTD1 TRIP12 | 8.37e-05 | 1000 | 47 | 10 | int:SMC5 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 9.02e-05 | 219 | 49 | 4 | chr7q22 | |
| Cytoband | 7q11.23 | 1.57e-04 | 97 | 49 | 3 | 7q11.23 | |
| Cytoband | 11p15.5 | 2.80e-04 | 118 | 49 | 3 | 11p15.5 | |
| Cytoband | 7q22 | 7.65e-04 | 38 | 49 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 3.07e-03 | 271 | 49 | 3 | chr7q11 | |
| GeneFamily | CD molecules|Mucins | 1.03e-20 | 21 | 31 | 9 | 648 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 5.85e-04 | 21 | 31 | 2 | 89 | |
| GeneFamily | Nucleoporins | 1.37e-03 | 32 | 31 | 2 | 1051 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.59e-03 | 161 | 31 | 3 | 593 | |
| GeneFamily | PHD finger proteins | 1.04e-02 | 90 | 31 | 2 | 88 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.70e-11 | 170 | 49 | 9 | M5880 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.92e-07 | 158 | 49 | 6 | MM17063 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.05e-06 | 751 | 49 | 10 | M5885 | |
| Coexpression | BIDUS_METASTASIS_UP | 3.47e-06 | 221 | 49 | 6 | M15866 | |
| Coexpression | NABA_MATRISOME | 1.65e-05 | 1026 | 49 | 10 | M5889 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.42e-05 | 466 | 49 | 7 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.58e-05 | 856 | 49 | 9 | M4500 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-08 | 176 | 49 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.42e-08 | 179 | 49 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-08 | 180 | 49 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.57e-08 | 180 | 49 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 5.04e-08 | 183 | 49 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.21e-08 | 184 | 49 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.91e-08 | 193 | 49 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-07 | 159 | 49 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-06 | 175 | 49 | 5 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-06 | 175 | 49 | 5 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 2.26e-06 | 193 | 49 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.43e-06 | 196 | 49 | 5 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-06 | 196 | 49 | 5 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.43e-06 | 196 | 49 | 5 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-06 | 196 | 49 | 5 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.49e-06 | 197 | 49 | 5 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 198 | 49 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.52e-05 | 136 | 49 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 136 | 49 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-05 | 173 | 49 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.56e-05 | 180 | 49 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-05 | 181 | 49 | 4 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.66e-05 | 181 | 49 | 4 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-05 | 181 | 49 | 4 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.66e-05 | 181 | 49 | 4 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-05 | 182 | 49 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 182 | 49 | 4 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 184 | 49 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 185 | 49 | 4 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 185 | 49 | 4 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 49 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 49 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 191 | 49 | 4 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 191 | 49 | 4 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 191 | 49 | 4 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 5.86e-05 | 192 | 49 | 4 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 5.86e-05 | 192 | 49 | 4 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.98e-05 | 193 | 49 | 4 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-05 | 194 | 49 | 4 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 6.22e-05 | 195 | 49 | 4 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.22e-05 | 195 | 49 | 4 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.22e-05 | 195 | 49 | 4 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-05 | 195 | 49 | 4 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 6.22e-05 | 195 | 49 | 4 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 195 | 49 | 4 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-05 | 196 | 49 | 4 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.35e-05 | 196 | 49 | 4 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 6.35e-05 | 196 | 49 | 4 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-05 | 196 | 49 | 4 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.35e-05 | 196 | 49 | 4 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.47e-05 | 197 | 49 | 4 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.47e-05 | 197 | 49 | 4 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.47e-05 | 197 | 49 | 4 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 6.47e-05 | 197 | 49 | 4 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 6.47e-05 | 197 | 49 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.47e-05 | 197 | 49 | 4 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.47e-05 | 197 | 49 | 4 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.47e-05 | 197 | 49 | 4 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.47e-05 | 197 | 49 | 4 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.60e-05 | 198 | 49 | 4 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.60e-05 | 198 | 49 | 4 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.60e-05 | 198 | 49 | 4 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 198 | 49 | 4 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.60e-05 | 198 | 49 | 4 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.60e-05 | 198 | 49 | 4 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.60e-05 | 198 | 49 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.60e-05 | 198 | 49 | 4 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | a8bfc0b93ad9968cf52a25be86995ffe436bd636 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Club|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.73e-05 | 199 | 49 | 4 | 111cfd589ec6795075d8d88d7664bfb23eba5bf6 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 199 | 49 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-05 | 199 | 49 | 4 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 199 | 49 | 4 | d583290a1d288b749ad17bc501c1487268c6551c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-05 | 199 | 49 | 4 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-05 | 199 | 49 | 4 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.73e-05 | 199 | 49 | 4 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-05 | 199 | 49 | 4 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 6.73e-05 | 199 | 49 | 4 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-05 | 199 | 49 | 4 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.73e-05 | 199 | 49 | 4 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.73e-05 | 199 | 49 | 4 | 2b17694cffbec28a2c8f165dfcff6bab94aa0f4c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.73e-05 | 199 | 49 | 4 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 199 | 49 | 4 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.73e-05 | 199 | 49 | 4 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 6.86e-05 | 200 | 49 | 4 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.22e-04 | 107 | 49 | 3 | d694e72244d0b79be7e47c393c06aa55d504aba8 | |
| ToppCell | TCGA-Stomach|World / Sample_Type by Project: Shred V9 | 2.22e-04 | 107 | 49 | 3 | f35fa6b05aacfd0bd6a8f9d5dbdd4a66212cc3cf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-double-positive,_alpha-beta_thymocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.19e-04 | 121 | 49 | 3 | 25fa58d8e07dab572b2ba8e23c9d1ad3502dfc56 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 125 | 49 | 3 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.51e-04 | 125 | 49 | 3 | b82ce58b6262b0739c788395766e5fc77d2744f2 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.68e-04 | 127 | 49 | 3 | d61b71572eab8a850ee8ce54323fb247525006e5 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 4.79e-04 | 139 | 49 | 3 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.75e-09 | 184 | 47 | 8 | 2321_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 8.92e-08 | 182 | 47 | 7 | 7067_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.62e-06 | 176 | 47 | 6 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.33e-05 | 179 | 47 | 5 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.42e-05 | 180 | 47 | 5 | 1793_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 3.61e-05 | 182 | 47 | 5 | 7085_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 3.90e-05 | 185 | 47 | 5 | 1114_DN | |
| Drug | rioprostil | 3.92e-05 | 32 | 47 | 3 | CID005311413 | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.54e-05 | 191 | 47 | 5 | 3861_UP | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 4.77e-05 | 193 | 47 | 5 | 7084_DN | |
| Drug | cellobiitol | 6.10e-05 | 37 | 47 | 3 | CID000003871 | |
| Disease | cholangiocarcinoma (is_marker_for) | 7.25e-08 | 64 | 49 | 5 | DOID:4947 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 8.10e-06 | 3 | 49 | 2 | DOID:9368 (is_marker_for) | |
| Disease | susceptibility to pneumonia measurement | 2.08e-05 | 97 | 49 | 4 | EFO_0008410 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.69e-05 | 5 | 49 | 2 | DOID:3030 (is_marker_for) | |
| Disease | dry eye syndrome (is_marker_for) | 1.21e-04 | 10 | 49 | 2 | DOID:10140 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.45e-04 | 61 | 49 | 3 | DOID:3587 (is_marker_for) | |
| Disease | pulmonary fibrosis | 1.47e-04 | 11 | 49 | 2 | EFO_0009448 | |
| Disease | cervical carcinoma | 2.39e-04 | 182 | 49 | 4 | EFO_0001061 | |
| Disease | gastric ulcer (implicated_via_orthology) | 2.43e-04 | 14 | 49 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | migraine disorder | 3.11e-04 | 357 | 49 | 5 | MONDO_0005277 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 3.19e-04 | 16 | 49 | 2 | EFO_0020346 | |
| Disease | pancreatic cancer (is_marker_for) | 6.40e-04 | 101 | 49 | 3 | DOID:1793 (is_marker_for) | |
| Disease | malaria | 6.58e-04 | 102 | 49 | 3 | EFO_0001068 | |
| Disease | Sjogren's syndrome (is_marker_for) | 7.28e-04 | 24 | 49 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Dwarfism | 7.91e-04 | 25 | 49 | 2 | C0013336 | |
| Disease | complement C4b measurement | 7.91e-04 | 25 | 49 | 2 | EFO_0008092 | |
| Disease | body weight | 1.03e-03 | 1261 | 49 | 8 | EFO_0004338 | |
| Disease | response to aromatase inhibitor | 1.30e-03 | 32 | 49 | 2 | GO_0061477 | |
| Disease | COVID-19 symptoms measurement | 1.55e-03 | 35 | 49 | 2 | EFO_0600019 | |
| Disease | ciliopathy (implicated_via_orthology) | 2.02e-03 | 40 | 49 | 2 | DOID:0060340 (implicated_via_orthology) | |
| Disease | autism spectrum disorder, schizophrenia | 2.12e-03 | 327 | 49 | 4 | EFO_0003756, MONDO_0005090 | |
| Disease | bipolar disorder | 2.64e-03 | 577 | 49 | 5 | MONDO_0004985 | |
| Disease | oropharynx cancer | 2.67e-03 | 46 | 49 | 2 | EFO_1001931 | |
| Disease | smoking status measurement, carotid artery intima media thickness | 2.90e-03 | 48 | 49 | 2 | EFO_0006527, EFO_0007117 | |
| Disease | eosinophil count | 2.92e-03 | 1488 | 49 | 8 | EFO_0004842 | |
| Disease | complement C4 measurement | 3.40e-03 | 52 | 49 | 2 | EFO_0004984 | |
| Disease | plasminogen activator inhibitor 1 measurement | 3.66e-03 | 54 | 49 | 2 | EFO_0004792 | |
| Disease | idiopathic pulmonary fibrosis | 4.07e-03 | 57 | 49 | 2 | EFO_0000768 | |
| Disease | cognitive behavioural therapy | 4.21e-03 | 58 | 49 | 2 | EFO_0007820 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.49e-03 | 200 | 49 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | cystic fibrosis (is_marker_for) | 4.79e-03 | 62 | 49 | 2 | DOID:1485 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSGSSTSSSSGSVST | 2351 | Q9P281 | |
| SSSSISSVSSVASSV | 316 | Q9UDT6 | |
| TTAATAAATTTTTTS | 536 | O60641 | |
| ATTATTASTTTTTVS | 2341 | Q12830 | |
| TASTTTTTVSTTAAG | 2346 | Q12830 | |
| TTTAVSASSTSSSAV | 221 | Q9ULK2 | |
| TTTATTTASTGSTAT | 1911 | Q9HC84 | |
| TTTATTITATGSTTN | 2691 | Q9HC84 | |
| QTTAATTTATTGSTA | 2996 | Q9HC84 | |
| TTTATTITATGSTTN | 3391 | Q9HC84 | |
| LTTTATTTESTGSTA | 3696 | Q9HC84 | |
| TELTTTATTTASTGS | 4251 | Q9HC84 | |
| TTTATTITATGSTTN | 4681 | Q9HC84 | |
| ATTTAATGSTATLSS | 4826 | Q9HC84 | |
| ISVSTEGANTSSSTS | 156 | Q02297 | |
| SSSTSTSTTGTSHLV | 166 | Q02297 | |
| DISTSTKSGSNTSSS | 396 | Q96NI6 | |
| ATTTVSTSATSLSAT | 981 | Q8WXI7 | |
| TSTSQKIGSSSDTST | 6371 | Q8WXI7 | |
| TQGTSTLDTSSTTSL | 7916 | Q8WXI7 | |
| VTTSGTSQTHSSFST | 2066 | Q6W4X9 | |
| TITSSASANTTTGTT | 1841 | Q2M2H8 | |
| ATTSSLTGTTDVSTS | 2121 | Q2M2H8 | |
| SETNTSTSVTSTQST | 1641 | Q8IWI9 | |
| ETSTSANTGSSVISS | 26 | Q5SSG8 | |
| GISIATNSESSTTSS | 101 | Q5SSG8 | |
| STTSSGTSTATNSES | 366 | Q5SSG8 | |
| GTSTATNSESSTVSS | 371 | Q5SSG8 | |
| STVSSGASTATTSES | 381 | Q5SSG8 | |
| GASTATTSESSTTSS | 386 | Q5SSG8 | |
| TTSESSTTSSGASTA | 391 | Q5SSG8 | |
| TTDSTTGSETTSAST | 66 | E2RYF6 | |
| STTVSGTTTTFTIAS | 131 | E2RYF6 | |
| ATVSTTGSETTTTST | 186 | E2RYF6 | |
| TGSETTTTSTASSEA | 191 | E2RYF6 | |
| TKVSTTGSETTTAST | 206 | E2RYF6 | |
| TTASTAGSETTTTST | 216 | E2RYF6 | |
| TTTSTSMAGSEATTT | 226 | E2RYF6 | |
| NTTTASTTGSETTTI | 266 | E2RYF6 | |
| TTTNSTTSSETTVTS | 376 | E2RYF6 | |
| TTSSETTVTSTAGSE | 381 | E2RYF6 | |
| TTVTSTAGSETTTVS | 386 | E2RYF6 | |
| TTTVSTAGSETTTVS | 446 | E2RYF6 | |
| TTTVSTTGSETTTAS | 456 | E2RYF6 | |
| TTVSTAGSETTAAST | 496 | E2RYF6 | |
| TTASTTGFETTAAST | 526 | E2RYF6 | |
| TTVSTTGSETTTASI | 596 | E2RYF6 | |
| STDSTTGSETTTAST | 616 | E2RYF6 | |
| TTASTEGSETTTAST | 626 | E2RYF6 | |
| TTASTEGSETTTVTT | 706 | E2RYF6 | |
| TTVSTTGSETTTVST | 786 | E2RYF6 | |
| TTVSTTGLETTTTST | 796 | E2RYF6 | |
| TTVSTTGAETTTDST | 816 | E2RYF6 | |
| TAASTAGSETTTVST | 836 | E2RYF6 | |
| TSASTTGSETTTAST | 866 | E2RYF6 | |
| TGSETTTASTTSSET | 871 | E2RYF6 | |
| TTASTTSSETTTAST | 876 | E2RYF6 | |
| TSSETTTASTEGSET | 881 | E2RYF6 | |
| TTASTEGSETTTVST | 886 | E2RYF6 | |
| KVSTTGSETTTTSTE | 956 | E2RYF6 | |
| TASTEGSETTSASTT | 996 | E2RYF6 | |
| SASTTGSETTTASTT | 1006 | E2RYF6 | |
| GSETTTASTTSSETT | 1011 | E2RYF6 | |
| TTTSTEGSETTTAST | 1096 | E2RYF6 | |
| TTASTEGSETTTAST | 1106 | E2RYF6 | |
| TTASTESSETTTATT | 1116 | E2RYF6 | |
| TTATTIGSETTTAST | 1126 | E2RYF6 | |
| TTASTEGSETTTTST | 1136 | E2RYF6 | |
| TTTSTEGSETTTAST | 1146 | E2RYF6 | |
| TTVSTTGSETTTAST | 1166 | E2RYF6 | |
| TTASTEGSETTTAST | 1176 | E2RYF6 | |
| TTASTAGSETTTVST | 1226 | E2RYF6 | |
| TTVSSTGSETTTVST | 1256 | E2RYF6 | |
| TAVYTTGSETTTTST | 1296 | E2RYF6 | |
| TTTSTEGSETTTVST | 1306 | E2RYF6 | |
| TTVSTTGSETTTAST | 1316 | E2RYF6 | |
| TTVSTSGSGTTTAST | 1336 | E2RYF6 | |
| TTVSTTSSETTTAST | 1376 | E2RYF6 | |
| TSSETTTASTTGSEM | 1381 | E2RYF6 | |
| TTVSTIGSEATTSSA | 1406 | E2RYF6 | |
| TTSSAAGSEATTTST | 1416 | E2RYF6 | |
| TTTSTEGSETTTAST | 1426 | E2RYF6 | |
| TTASTAGSETTTAST | 1436 | E2RYF6 | |
| TTASTAGSETTTAST | 1446 | E2RYF6 | |
| TASGATAASTTVSST | 1521 | E2RYF6 | |
| AATTTTVTTKSSSSS | 156 | Q86Z02 | |
| SGTLSTSTSISSQIS | 1536 | O60333 | |
| SVSGSSSSKIISTTT | 501 | P19013 | |
| SSETASSGLTSKTSS | 311 | Q9NXV6 | |
| STSLSSSTSTEGSGT | 906 | Q5SYE7 | |
| TTGTGQTTFTSSTAT | 1721 | Q02505 | |
| LTSSITTTETTSHST | 2026 | Q02505 | |
| SFSSSITTTETTSHS | 2221 | Q02505 | |
| SFTSSITTTETTSHS | 2306 | Q02505 | |
| TTTETNSHSTTSFTS | 2346 | Q02505 | |
| TSFTSSITTTETTSH | 2356 | Q02505 | |
| FTSSITTTETTSEST | 2426 | Q02505 | |
| ASGSSSSATTVTSKV | 656 | Q7LBC6 | |
| GTSSSTVSHTTGNTT | 146 | Q9UQV4 | |
| STTSKTTETQASGSS | 1866 | P98088 | |
| TTSASTTSTTSGAGT | 2516 | P98088 | |
| TASTTSASTTSTTSG | 2641 | P98088 | |
| TTSTTSASTTSTTSG | 2681 | P98088 | |
| TTSTTSASTTSTTSG | 2961 | P98088 | |
| TTSTTSAATTSTISA | 3081 | P98088 | |
| TSTTSASTASKTSGL | 3106 | P98088 | |
| TSAATSSTTSGSGTT | 3471 | P98088 | |
| TSKTSAATSSTTSGS | 3901 | P98088 | |
| QTSKTSAATSSTTSG | 4206 | P98088 | |
| TTSTTSASTASTTSG | 4526 | P98088 | |
| GTSTTTSTAATATAT | 266 | P37198 | |
| TATATTTSSSSTTGF | 276 | P37198 | |
| SGSGASSTTTATSTT | 3476 | Q7Z6Z7 | |
| SDASSASGTAVTTTS | 391 | P52756 | |
| STSSVSSTGSSSLLE | 121 | P23677 | |
| GINSVSSSSVSTTTS | 816 | A8CG34 | |
| SSVSTTTSTATAASQ | 846 | Q96HA1 | |
| TTTTTTAAATTTTES | 1086 | O94856 | |
| QTHSSGTVTSSSSTA | 2001 | Q14008 | |
| GSSSSASTSTLTAET | 1441 | Q9ULT8 | |
| STSSVTSSSNVATAT | 1611 | Q9ULT8 | |
| QAIHGSTTSTTSSSS | 166 | Q9Y2E4 | |
| STTSTTSSSSTQSGG | 171 | Q9Y2E4 | |
| GSSTVSKSSVSASES | 181 | Q5VTH9 | |
| SAAGATATTSTSSTV | 771 | Q9ULU4 | |
| GVTTSTTTNTTTAAT | 696 | Q9H329 | |
| SSSSSRSETGVITSS | 596 | O75928 | |
| TTSTEATSSSTTAEG | 661 | Q685J3 | |
| SSSTTAEGSSMTIST | 1611 | Q685J3 | |
| TTSTEATSSTTAEGT | 3196 | Q685J3 | |
| TAETSSGATSTTTTT | 426 | Q12872 | |
| STSSSTVTSSAGSEQ | 181 | Q8N488 | |
| STAITASSSTSISGS | 291 | O00444 | |
| SVSSGSSVSSTSLDT | 211 | Q9NZQ3 | |
| YGADTTTATTTTTTS | 36 | Q6ZVD8 | |
| STTSTTTTATSVAQT | 281 | O14776 | |
| TQSSATTSTTTSTGS | 326 | Q9UHD9 | |
| STTSVSSGTATAATH | 956 | Q14669 | |
| TSSELSTSTSEGSLS | 791 | Q68DK2 | |
| ASTTSSGVSEESTTS | 2066 | Q9UKN1 | |
| TTTSSGVSEESSTSH | 2541 | Q9UKN1 | |
| TTSSGVSEESSTSHS | 3016 | Q9UKN1 | |
| STTSSGVSEESTTSH | 3266 | Q9UKN1 | |
| TTTSGSSQESTTSHS | 3681 | Q9UKN1 | |
| ASTTTSGLSQESTTF | 4926 | Q9UKN1 | |
| STTTKITTGSSSAGT | 591 | O14974 | |
| TTLTTTTAGTVSSTT | 646 | O14974 |